DJIA 17,195.42 221.11 1.30%
NASDAQ 4,566.14 16.91 0.37%
S&P 500 1,994.65 12.35 0.62%
market minute promo

Epizyme (NASDAQ: EPZM)

27.24 1.01 (3.85%)

Quote as of


company name or ticker

Recent Quotes

EPZM $27.24 3.85%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $26.12
Previous Close $26.23
Daily Range $26.12 - $27.38
52-Week Range $18.10 - $42.00
Market Cap $914.8M
P/E Ratio 27.04
Dividend (Yield) $0.00 (0.0%)
Volume 288,694
Average Daily Volume 306,895
Current FY EPS -$1.68

Sector

Industry

Epizyme (EPZM) Description

Epizyme Inc is a clinical stage biopharmaceutical company that discovers develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers. Website: http://www.epizyme.com/

News & Commentary

Why Epizyme Inc. Shares Rocketed Higher

Epizyme shares soar after the company reaches another creative milestone with partner GlaxoSmithKline.

Can Epizyme (EPZM) Surprise This Earnings Season? - Analyst Blog

What Falling Estimates & Price Mean for Enzo Biochem (ENZ) - Tale of the Tape

Protalix BioTherapeutics, Inc. (PLX) in Focus: Stock Surges 11.4% - Tale of the Tape

Alnylam Pharmaceuticals (ALNY) Jumps: Stock Rises 19% - Tale of the Tape

Epizyme Announces Clinical And Pre-Clinical Data To Be Featured In Oral And Poster Presentations At

Epizyme Announces Clinical And Pre-Clinical Data To Be Featured In Oral And Poster Presentations At American Society Of Hematology (ASH) Annual Meeting

Commit To Purchase Epizyme At $22.50, Earn 19.4% Annualized Using Options

Epizyme (EPZM) Downgraded From Hold to Sell

UPDATE: Mizuho Securities USA Initiates Coverage On Epizyme Inc On Epigenetics Pure Play

Benzinga's Top Initiations

Why Epizyme (EPZM) Stock Might be a Great Pick - Tale of the Tape

Why Epizyme (EPZM) Stock Might be a Great Pick - Tale of the Tape

See More EPZM News...